反応式
CN1CCN(C2C=CC(N[C:15]([C:17]3[C:18]4[N:19]=[CH:20][CH:21]=[N:22][C:23]=4[C:24]([C:27]4[C:36]5[C:31](=[CH:32][CH:33]=[CH:34][CH:35]=5)[CH:30]=[CH:29][CH:28]=4)=[CH:25][CH:26]=3)=[O:16])=CC=2)CC1.CO.C1COCC1.CO.[CH3:46][N:47]1[CH2:52][CH2:51][N:50]([CH2:53][C:54]2[N:55]=[C:56]([N+:59]([O-])=O)[NH:57][CH:58]=2)[CH2:49][CH2:48]1>[Ni].C(Cl)Cl.CO>[CH3:46][N:47]1[CH2:52][CH2:51][N:50]([CH2:53][C:54]2[N:55]=[C:56]([NH:59][C:15]([C:17]3[C:18]4[N:19]=[CH:20][CH:21]=[N:22][C:23]=4[C:24]([C:27]4[C:36]5[C:31](=[CH:32][CH:33]=[CH:34][CH:35]=5)[CH:30]=[CH:29][CH:28]=4)=[CH:25][CH:26]=3)=[O:16])[NH:57][CH:58]=2)[CH2:49][CH2:48]1参加物
7
実験手順
The title compound was prepared in analogy to the procedures described in Example 14 but using 8-naphthalen-1-yl-quinoxaline-5-carboxylic acid (Example 46) in Step 14.1, Raney nickel and MeOH/THF (1:1) instead of palladium on carbon and MeOH in Step 14.2 and 1-methyl-4-(2-nitro-1H-imidazol-4-ylmethyl)-piperazine (Step 20.1) instead of 2-nitroimidazole in Step 14.3. Title compound: ESI-MS: 478.1 [M+H]+; tR=3.36 min (System 1); TLC: Rf=0.15 (DCM/MeOH, 9:1).
後処理
- customThe title compound was prepared in analogy to the procedures
出典と根拠
- ORDレコード
- ord-2ca717b309df491c833649020f262490
- 出典データセット
- uspto-grants-2013_09
- 特許番号
- US08536175B2
関連ノート
読み込み中…